LianBio - ADR
General ticker "LIAN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $450.6M
LianBio - ADR follows the US Stock Market performance with the rate: 6.1%.
Estimated limits based on current volatility of 5.3%: low 0.28$, high 0.31$
Factors to consider:
- Earnings expected soon, date: 2024-05-09
- Earnings for 12 months up through Q4 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term predictions were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 predicted range: [0.77$, 2.31$]
- 2023-12-31 to 2024-12-30 predicted range: [0.66$, 1.94$]
Short-term LIAN quotes
Long-term LIAN plot with estimates
Financial data
| YTD | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $134.87MM | $195.57MM | $125.35MM |
| Operating Income | $-134.87MM | $-195.57MM | $-125.35MM |
| Non-Operating Income | $-4.73MM | $-0.21MM | $14.73MM |
| Interest Expense | $0.00MM | $0.24MM | $0.00MM |
| R&D Expense | $120.89MM | $158.69MM | $59.76MM |
| Income(Loss) | $-139.60MM | $-195.78MM | $-110.62MM |
| Taxes | $0.00MM | $0.52MM | $-0.33MM |
| Profit(Loss) | $-139.60MM | $-196.30MM | $-110.29MM |
| Stockholders Equity | $-132.84MM | $353.56MM | $259.87MM |
| Assets | $279.29MM | $426.34MM | $319.96MM |
| Operating Cash Flow | $-98.14MM | $-163.95MM | $-99.19MM |
| Investing Cash Flow | $-0.89MM | $-155.94MM | $-69.20MM |
| Financing Cash Flow | $309.75MM | $313.27MM | $1.71MM |
| Earnings Per Share* | $-1.33 | $-5.71 | $-1.02 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.